• Optimizing conjugation processes to improve the stability and efficacy of ADCs
• Developing new linker technologies to enhance the precision of antibody drug conjugation
• Implementing analytical methods to assess the quality and potency of ADCs
• Addressing challenges in scaling up ADC production while maintaining product integrity
• Collaborating with clinical teams to align ADC development with therapeutic goals
• Ensuring compliance with regulatory guidelines for the development and manufacturing of ADCs